Tytuł pozycji:
Trastuzumab emtansine (T-DM1) versus trastuzumab in Chinese patients with residual invasive disease after neoadjuvant chemotherapy and HER2-targeted therapy for HER2-positive breast cancer in the phase 3 KATHERINE study
-
Tytuł:
-
Trastuzumab emtansine (T-DM1) versus trastuzumab in Chinese patients with residual invasive disease after neoadjuvant chemotherapy and HER2-targeted therapy for HER2-positive breast cancer in the phase 3 KATHERINE study
-
Autorzy:
-
Huang, Chiun-Sheng
Yang, Youngsen
Kwong, Ava
Chen, Shin-Cheh
Tseng, Ling-Ming
Liu, Mei-Ching
Shen, Kunwei
Wang, Shusen
Ng, Ting-Ying
Feng, Yi
Sun, Guofang
Yan, Iris Renfei
Shao, Zhimin
-
Źródło:
-
Breast Cancer Research and Treatment. 187(3):759-768
-